We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Mylan Pharmaceuticals has received final FDA approval for generic versions of Sciele Pharma’s anti-hypertensive Sular extended release (ER) in 20-, 30- and 40-mg strengths.